Very low doses of GM-CSF administered alone or with erythropoietin in a plastic anemia
- 31 July 1992
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 93 (1) , 41-48
- https://doi.org/10.1016/0002-9343(92)90678-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A phase I/II trial of recombinant granulocyte-macrophage colony- stimulating factor for children with aplastic anemiaBlood, 1990
- Recombinant Human Erythropoietin for Patients with AIDS Treated with ZidovudineNew England Journal of Medicine, 1990
- Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage-colony-stimulating factorBlood, 1989
- Stimulation of Myelopoiesis in Patients with Aplastic Anemia by Recombinant Human Granulocyte-Macrophage Colony-Stimulating FactorNew England Journal of Medicine, 1988
- Failure of recombinant human granulocyte-macrophage colony-stimulating factor therapy in aplastic anemia patients with very severe neutropeniaBlood, 1988
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- Phase I/II study of recombinant human granulocyte-macrophage colony- stimulating factor in aplastic anemia and myelodysplastic syndromeBlood, 1988
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987